Cart
sales@molnova.com
3-Bromobenzoic acid
CAS No. 585-76-2
3-Bromobenzoic acid( m-Bromobenzoic acid | 3-Bromo-benzoic acid | 3-Bromobenzoicacid )
Catalog No. M29526 CAS No. 585-76-2
3-Bromobenzoic acid is a marine derived natural products found in Tubastraea micranthus.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 27 | In Stock |
|
Biological Information
-
Product Name3-Bromobenzoic acid
-
NoteResearch use only, not for human use.
-
Brief Description3-Bromobenzoic acid is a marine derived natural products found in Tubastraea micranthus.
-
Description3-Bromobenzoic acid is a marine derived natural products found in Tubastraea micranthus.
-
In Vitro——
-
In Vivo——
-
Synonymsm-Bromobenzoic acid | 3-Bromo-benzoic acid | 3-Bromobenzoicacid
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number585-76-2
-
Formula Weight201.02
-
Molecular FormulaC7H5BrO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(O)C=1C=CC=C(Br)C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Seglitide
Peptide agonist for sst2 and sst5 somatostatin receptors. IC50/Kd values (nM) at cloned human somatostatin receptors are: > 1000 (sst1), 0.2 - 1.5 (sst2), 27 - 36 (sst3), > 127 (sst4), and 0.06 - 23 (sst5).
-
2'-Deoxyuridine 5'-m...
2'-Deoxyuridine 5'-monophosphate (dUMP) is used by the enzyme thymidylate synthetase (TS) for the de novo production of dTMP. dUMP is used as the reference substrate in studies of dUMP analogues in potential chemotherapy applications.
-
5-Methyluridine
Ribothymidine is an endogenous methylated nucleoside found in human fluids; methylated purine bases are present in higher amounts in tumor-bearing patients compared to healthy controls.DNA hypermethylation is a common finding in malignant cells and has been explored as a therapeutic target for hypomethylating agents.
